It allows researchers to examine whether infection is associated with barrier disruption while simultaneously tracking microbial growth and host responses. These measurements connect physical damage in skin with inflammatory signaling and immune-cell recruitment. Comparing these outcomes across conditions helps clarify how epithelial defenses and innate immunity contribute to limiting infection.
These platforms represent different levels of skin organization. Cultured keratinocytes provide an epithelial setting, reconstructed tissue adds a more skin-like structure, and animal skin supplies an intact biological context. The choice determines which features of barrier disruption, microbial growth, inflammatory signaling, or immune-cell recruitment can be examined under controlled experimental conditions.
Key measurements include changes in the skin barrier, the amount or pattern of microbial growth, inflammatory signaling, and recruitment of immune cells. Together, these readouts show both tissue-level damage and defense activity. This combination is useful because a treatment or pathogen may affect microbial growth and host inflammation differently.
Controlled conditions make it easier to attribute differences in infection outcomes to the selected pathogen or intervention rather than to uncontrolled variation in the experimental system. Researchers can then compare barrier disruption, microbial growth, inflammatory signaling, and immune-cell recruitment across treatments or infection settings with greater reproducibility.
A typical workflow begins by selecting a skin platform, such as cultured keratinocytes, reconstructed tissue, or animal skin, and pairing it with a selected pathogen. Researchers then assess infection through barrier disruption, microbial growth, inflammatory signaling, and immune-cell recruitment. The resulting measurements support comparisons among pathogens, treatments, or therapeutic strategies.
Selection depends on which aspect of infection the study needs to reproduce and measure. Cultured keratinocytes, reconstructed skin tissue, and animal skin offer progressively different experimental contexts for examining host defense and microbial effects. Researchers can match the platform to the desired analysis while maintaining conditions suitable for reproducible comparisons.
They are useful when researchers need controlled evidence about how an intervention affects infection-related outcomes before clinical testing. Measurements of microbial growth can indicate antimicrobial activity, while barrier disruption, inflammatory signaling, and immune-cell recruitment reveal effects on tissue damage and host defense. The same framework can also support studies of pathogen virulence mechanisms.